The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 27744182 |
16 |
Rapid preparation of (3R,4S,5R) polyhydroxylated pyrrolidine-based libraries to discover a pharmacological chaperone for treatment of Fabry disease. |
National Cheng Kung University |
| 27474919 |
10 |
Bioevaluation of sixteen ADMDP stereoisomers toward alpha-galactosidase A: Development of a new pharmacological chaperone for the treatment of Fabry disease and potential enhancement of enzyme replacement therapy efficiency. |
National Cheng Kung University |
| 26838810 |
16 |
Synthesis of C-5a-chain extended derivatives of 4-epi-isofagomine: Powerfulß-galactosidase inhibitors and low concentration activators of GM1-gangliosidosis-related human lysosomalß-galactosidase. |
Graz University of Technology |
| 15771446 |
42 |
Biological properties of D- and L-1-deoxyazasugars. |
Toyama Medical and Pharmaceutical University |
| 9651160 |
52 |
Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. |
Hokuriku University |
| 20457528 |
22 |
2,5-Dideoxy-2,5-imino-d-altritol as a new class of pharmacological chaperone for Fabry disease. |
University of Toyama |
| | 37 |
Synthesis of a new inhibitor of α-fucosidase |
TBA |
| | 5 |
Synthesis of C2-symmetrical polyhydroxyazepanes as inhibitors of glycosidases |
TBA |
| 14684301 |
3 |
Novel O-glycosyl amino acid mimetics as building blocks for O-glycopeptides act as inhibitors of galactosidases. |
University of Hamburg |
| 10021944 |
8 |
Specific, uncompetitive inhibition of beta-galactosidases by a 5,6-isopropylidenedioxyfuro[2,3-d]isoxazole-3-methanol derivative. |
Institut De Chimie Organique De L'Université |
| 28692917 |
21 |
Tuning of ?-glucosidase and ?-galactosidase inhibition by generation and in situ screening of a library of pyrrolidine-triazole hybrid molecules. |
University of Seville |
| 29289886 |
6 |
Synthesis of (3S,4S,5S)-trihydroxylpiperidine derivatives as enzyme stabilizers to improve therapeutic enzyme activity in Fabry patient cell lines. |
National Yang-Ming University |
Search and Browse
